When LSD guru Timothy Leary urged the nation's youth to “turn on, tune in, and drop out” in the 1960s, he was following a path already tread by radiologist and internist Dr. Mortimer A. Hartman, who dabbled in psychology and sold LSD to Hollywood A-listers, including Cary Grant.
When LSD guru Timothy Leary urged the nation's youth to “turn on, tune in, and drop out” in the 1960s, he was following a path already tread by radiologist and internist Dr. Mortimer A. Hartman, who dabbled in psychology and sold LSD to Hollywood A-listers, including Cary Grant.
Grant's escapades with LSD are chronicled in Evenings with Cary Grant: Recollections in His Own Words and by Those Who Knew Him Best, a book by Nancy Nelson that is excerpted in the August issue of Vanity Fair. Describing his LSD experiences, Grant said, “I ran the gamut of emtions, from deep pain with tears to light-headed laughter. For me, it was an experiment, and it was always monitored under Dr. Hartman’s care.” Dr.Hartman concluded, “LSD was not recreational for Cary. It was a very serious experiment.” Once LSD became illegal in California, Grant and Hartman discontinued its use, the article said.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.
Study: Abbreviated Breast MRI Offers Equivalent Accuracy to mpMRI for Women with Dense Breasts
May 20th 2025Emerging research suggests that abbreviated breast MRI offers comparable sensitivity and specificity as multiparametric MRI in women with extremely dense breasts with a nearly 50 percent reduction in reading time for radiologists.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.